HK inno.N releases new drug for GERD in Indonesia

HK inno.N releases new drug for GERD in Indonesia

South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...

HK inno.N's K-CAB to get insurance benefits in China

HK inno.N's K-CAB to get insurance benefits in China

South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...

HK inno.N gets approval to sell K-CAB in Singapore

HK inno.N gets approval to sell K-CAB in Singapore

South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...

New drug developer Onconic Therapeutics raises $20 mn in Series B

New drug developer Onconic Therapeutics raises $20 mn in Series B

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...

HK inno.N receives sales permit for ulcer treatment in China

HK inno.N receives sales permit for ulcer treatment in China

HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...

Yes, it’s K-beauty: Buying interest for makeup brands runs high even before they're up for sale Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany
banner